
Serina Therapeutics, Inc.
SERNYSECIK 1708599HealthcareFiscal year ends Dec 31
Reports and events: 242 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2025-01-0616:07 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001708599-25-000002 |
| 2024-12-2619:50 ET | 8-K | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 9.01 Financial statements and exhibits | 0001708599-24-000033 |
| 2024-12-1816:16 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001708599-24-000029 |
| 2024-12-1106:11 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-24-049549 |
| 2024-12-0916:45 ET | SC 13D/A | Ownership report, active investor, amended | 0001104659-24-126791 |
| 2024-12-0217:16 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-048316 |
| 2024-11-1217:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-24-044830 |
| 2024-11-1216:03 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001708599-24-000026 |
| 2024-11-0606:32 ET | DEF 14A | Proxy statementPeriod 2024-12-13 | 0001708599-24-000014 |
| 2024-10-0208:30 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-24-039111 |
| 2024-09-1217:17 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-24-036080 |
| 2024-09-0520:03 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-24-035028 |
| 2024-08-1617:54 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001493152-24-032700 |
| 2024-08-0916:25 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-24-030996 |
| 2024-08-0916:20 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001493152-24-030988 |
| 2024-07-2908:30 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-24-029379 |
| 2024-07-1817:06 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-028363 |
| 2024-07-1216:52 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001493152-24-027113 |
| 2024-07-0516:01 ET | SC 13D/A | Ownership report, active investor, amended | 0001104659-24-078084 |
| 2024-07-0317:03 ET | S-1/A | Registration statement, amended | 0001493152-24-026232 |
| 2024-06-1721:04 ET | S-1/A | Registration statement, amended | 0001493152-24-024004 |
| 2024-06-1016:05 ET | 8-K | 8.01 Other events | 0001493152-24-023333 |
| 2024-05-1416:25 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-24-019262 |
| 2024-05-1416:16 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001493152-24-019248 |
| 2024-05-0317:25 ET | S-1 | Registration statement | 0001493152-24-017773 |
| 2024-05-0316:42 ET | 8-K | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001493152-24-017731 |
| 2024-04-1716:22 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-24-015037 |
| 2024-04-0320:26 ET | SC 13D | Ownership report, active investor | 0001493152-24-013076 |
| 2024-04-0117:27 ET | 8-K | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 2.03 New direct financial obligation; 3.03 Change to security holders’ rights; 5.01 Change in control; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-012530 |
| 2024-03-2616:03 ET | SC 13D/A | Ownership report, active investor, amended | 0001104659-24-039008 |
| 2024-03-2217:28 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-24-011024 |
| 2024-03-2217:27 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001493152-24-011022 |
| 2024-03-1416:12 ET | 8-K | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-009959 |
| 2024-03-0716:47 ET | 8-K | 2.03 New direct financial obligation; 8.01 Other events | 0001493152-24-009224 |
| 2024-03-0707:47 ET | SC 13D/A | Ownership report, active investor, amended | 0001104659-24-031701 |
| 2024-02-1416:15 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001493152-24-006677 |
| 2024-02-1416:01 ET | SC 13D/A | Ownership report, active investor, amended | 0001104659-24-023562 |
| 2024-02-0616:05 ET | 8-K | 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 5.01 Change in control; 8.01 Other events | 0001493152-24-005085 |
| 2024-02-0507:19 ET | SC 13D/A | Ownership report, active investor, amended | 0001104659-24-010355 |
| 2024-01-1916:05 ET | 8-K | 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001493152-24-003057 |
| 2024-01-1716:19 ET | SC 13D/A | Ownership report, active investor, amended | 0001104659-24-004483 |
| 2024-01-1116:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-24-002061 |
| 2024-01-0916:16 ET | SC 13D/A | Ownership report, active investor, amended | 0001104659-24-002596 |
| 2024-01-0516:05 ET | 8-K | 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001493152-24-001398 |
| 2023-12-2816:02 ET | 8-K | 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001493152-23-046371 |
| 2023-12-1816:25 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001493152-23-045275 |
| 2023-12-1317:11 ET | SC 13D/A | Ownership report, active investor, amended | 0001104659-23-125774 |
| 2023-12-0816:05 ET | 8-K | 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001493152-23-044224 |
| 2023-12-0116:05 ET | 8-K | 1.02 Termination of a material agreement; 5.02 Departure or appointment of officers or directors | 0001493152-23-043393 |
| 2023-11-1716:05 ET | 8-K | 2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-23-041874 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 13, 2026, 15:52 ET. Listed shows no prices and gives no investment advice.